Central and peripheral GLP-1 systems independently suppress eating.
Nat Metab · 2021
Last updated 2026-05-28Research in mice found that the brain’s own GLP-1 system and the gut’s GLP-1 system each reduce eating through separate pathways, rather than working as one connected circuit. Blocking the brain’s GLP-1 signals did not stop gut-based GLP-1 drugs from working, and activating the brain’s GLP-1 system at the same time as giving a gut-based drug reduced eating even more than the drug alone.
AI summary of the abstract below.
| Journal | Nat Metab, 2021 |
|---|---|
| Citations | 223 |
| Relative citation ratio | 16.45 |
| NIH percentile | 99 |
| Molecules | — |
| Conditions studied | Obesity |
Abstract
The anorexigenic peptide glucagon-like peptide-1 (GLP-1) is secreted from gut enteroendocrine cells and brain preproglucagon (PPG) neurons, which, respectively, define the peripheral and central GLP-1 systems. PPG neurons in the nucleus tractus solitarii (NTS) are widely assumed to link the peripheral and central GLP-1 systems in a unified gut-brain satiation circuit. However, direct evidence for this hypothesis is lacking, and the necessary circuitry remains to be demonstrated. Here we show that PPG neurons encode satiation in mice, consistent with vagal signalling of gastrointestinal distension. However, PPG neurons predominantly receive vagal input from oxytocin-receptor-expressing vagal neurons, rather than those expressing GLP-1 receptors. PPG neurons are not necessary for eating suppression by GLP-1 receptor agonists, and concurrent PPG neuron activation suppresses eating more potently than semaglutide alone. We conclude that central and peripheral GLP-1 systems suppress eating via independent gut-brain circuits, providing a rationale for pharmacological activation of PPG neurons in combination with GLP-1 receptor agonists as an obesity treatment strategy.
Verbatim abstract via PubMed 33589843 ↗